| 10766881 |
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases |
Steven W. Andrews, James F. Blake, Adam Cook, Indrani W. Gunawardana, Kevin W. Hunt +3 more |
2020-09-08 |
| 10745419 |
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile |
Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more |
2020-08-18 |
| 10730880 |
4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors |
Shelley Allen, Mark Laurence Boys, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +13 more |
2020-08-04 |
| 10647715 |
KRas G12C inhibitors |
Matthew Arnold Marx, Thomas P. Bobinski, Aaron Craig Burns, John Gaudino, Julia Haas +5 more |
2020-05-12 |
| 10633381 |
KRas G12C inhibitors |
James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Jay Bradford Fell +11 more |
2020-04-28 |
| 10584124 |
Crystalline forms |
Andrew T. Metcalf, David Philip Fry, Elizabeth A. McFaddin, Gabrielle R. Kolakowski, Julia Haas +1 more |
2020-03-10 |
| 10555944 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors |
Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, Adam Cook +9 more |
2020-02-11 |